MemorialCare Heart and Vascular Institute Participating in Global Study of CSL112 in Patients with Acute Coronary Syndrome (AEGIS-II)

Study to evaluate the efficacy and safety of infusion therapy to reduce risk of second heart attack or stroke by removing cholesterol from arteries

Related Keywords

Fountain Valley ,California ,United States ,Laguna Hills ,Los Angeles ,Todd Zynda ,Sarah Elsayed ,John Bahadorani ,David Shavelle ,Centers For Disease ,Memorialcare Heart Vascular Institute ,Memorialcare Saddleback Medical Center ,World Health Organization ,Memorialcare Orange Coast Medical Center ,Memorialcare Long Beach Medical Center ,Memorialcare Heart ,Vascular Institute ,Mai Event ,Ischemic Syndromes ,Disease Control ,Memorialcare Saddleback Medical ,Apolipoproteina I ,Memorialcare Long Beach Medical ,Memorialcare Orange Coast Medical ,